Page last updated: 2024-10-26

famotidine and Pyrexia

famotidine has been researched along with Pyrexia in 2 studies

Famotidine: A competitive histamine H2-receptor antagonist. Its main pharmacodynamic effect is the inhibition of gastric secretion.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Mohseni, M1
Raissi, V1
Sharifan, Y1
Barikro, K1
Amiri, S1
Mohseni, MS1
Raeisi, F1
Masoumi, K1
Khodakarami, S1
Raiesi, O1
Norwood, J1
Smith, TM1
Stein, DS1

Reviews

1 review available for famotidine and Pyrexia

ArticleYear
Therapeutic Status of Famotidine in COVID-19 Patients: A Review.
    Infectious disorders drug targets, 2022, Volume: 22, Issue:3

    Topics: COVID-19 Drug Treatment; Famotidine; Fever; Histamine; Humans; SARS-CoV-2

2022

Other Studies

1 other study available for famotidine and Pyrexia

ArticleYear
Famotidine and hyperpyrexia.
    Annals of internal medicine, 1990, Apr-15, Volume: 112, Issue:8

    Topics: Adult; Famotidine; Fever; Humans; Male

1990